The DOI matches its Crossref record.
Ginger for Prevention of Antituberculosis-induced Gastrointestinal Adverse Reactions Including Hepatotoxicity: A Randomized Pilot Clinical Trial: Ginger and Antituberculosis Adverse Reactions
Abstract
In this study, the potential benefits of ginger in preventing antituberculosis drug-induced gastrointestinal adverse reactions including hepatotoxicity have been evaluated in patients with tuberculosis. Patients in the ginger and placebo groups (30 patients in each group) received either 500 mg ginger (Zintoma)(®) or placebo one-half hour before each daily dose of antituberculosis drugs for 4 weeks. Patients' gastrointestinal complaints (nausea, vomiting, dyspepsia, and abdominal pain) and antituberculosis drug-induced hepatotoxicity were recorded during the study period. In this cohort, nausea was the most common antituberculosis drug-induced gastrointestinal adverse reactions. Forty eight (80%) patients experienced nausea. Nausea was more common in the placebo than the ginger group [27 (90%) vs 21 (70%), respectively, p = 0.05]. During the study period, 16 (26.7%) patients experienced antituberculosis drug-induced hepatotoxicity. Patients in the ginger group experienced less, but not statistically significant, antituberculosis drug-induced hepatotoxicity than the placebo group (16.7% vs 36.7%, respectively, p = 0.07). In conclusion, ginger may be a potential option for prevention of antituberculosis drug-induced gastrointestinal adverse reactions including hepatotoxicity. Copyright © 2016 John Wiley & Sons, Ltd.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nausea was more common in the placebo than the ginger group”
From Ginger in gastrointestinal disorders: A systematic review of clinical trials (2019) · cites this paper as Emrani, Shojaei, & Khalili (2016)
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 38
- Ali, 2008, Some phytochemical, pharmacological and toxicological properties of ginger: a review of recent research, Food Chem Toxicol, 46, 409, 10.1016/j.fct.2007.09.085 · DOI · Paper page
- Altug, 2013, Effect of ginger extract on liver damage in experimental obstructive jaundice produced by main bile duct ligation, Acta Chir Belg, 113, 8, 10.1080/00015458.2013.11680877 · doi:10.1080/00015458.2013.11680877
- Atta, 2010, Hepatoprotective effect of methanol extracts of zingiberofficinale and cichoriumintybus, Indian J Pharm Sci, 72, 564, 10.4103/0250-474X.78521 · doi:10.4103/0250-474x.78521
- Becker, 2010, Nausea, vomiting, and hiccups: a review of mechanisms and treatment, Anesth Prog, 57, 150, 10.2344/0003-3006-57.4.150 · DOI · Paper page
- ClarkVetri, 1999, Management of chemotherapy induced emesis, Pharm Times, 65, 7885
- Dabaghzadeh, 2014a, Ginger for prevention or treatment of drug-induced nausea and vomiting, Curr Clin Pharmacol, 9, 387, 10.2174/1574884708666131111205736 · DOI
- Dabaghzadeh, 2014b, Ginger for prevention of antiretroviral-induced nausea and vomiting: a randomized clinical trial, Expert Opin Drug Saf, 13, 859, 10.1517/14740338.2014.914170 · DOI · Paper page
- Danan, 1993, Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries, J Clin Epidemiol, 46, 1323, 10.1016/0895-4356(93)90101-6 · DOI · Paper page
- Ergul, 2010, Effect of vitamin C on oxidative liver injury due to isoniazid in rats, Pediatr Int, 52, 69, 10.1111/j.1442-200X.2009.02891.x · DOI
- Farazi, 2014, Adverse reactions to antituberculosis drugs in Iranian tuberculosis patients, Tuberc Res Treat, 2014
- Haniadka, 2013, Ginger protects the liver against the toxic effects of xenobiotic compounds: preclinical observations, J Nutr Food Sci, 3, 226
- Hatamkhani, 2014, Carnitine for prevention of antituberculosis drug-induced hepatotoxicity: a randomized, clinical trial, J Gastroenterol Hepatol, 29, 997, 10.1111/jgh.12474 · DOI
- Khalili, 2008, Assessment of adherence to tuberculosis drug regimen, DARU, 16, 47
- Khalili, 2009, Anti-tuberculosis drugs related hepatotoxicity; incidence, risk factors, pattern of changes in liver enzymes and outcome, DARU, 17, 163
- Langner, 1998, Ginger: history and use, Adv Ther, 15, 25
- Liu, 2008, Drugs and herbs given to prevent hepatotoxicity of tuberculosis therapy: systematic review of ingredients and evaluation studies, BMC Public Health, 8, 365, 10.1186/1471-2458-8-365 · doi:10.1186/1471-2458-8-365
- Maciel, 2010, Adverse effects of the new tuberculosis treatment regimen recommended by the Brazilian Ministry of Health, J Bras Pneumol, 36, 232, 10.1590/S1806-37132010000200012 · doi:10.1590/s1806-37132010000200012
- Mahesh, 2005, Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods, Pharmazie, 60, 83
- Motawi, 2011, Zingiber officinale acts as a nutraceutical agent against liver fibrosis. Nutr Metab 2011;8:40. 47. Sahebkar A. Potential efficacy of ginger as a natural supplement for nonalcoholic fatty liver disease, World J Gastroenterol, 17, 271
- Naranjo, 1981, A method for estimating the probability of adverse drug reactions, Clin Pharmacol Ther, 30, 239, 10.1038/clpt.1981.154 · DOI · Paper page
- Pertz, 2011, Effects of ginger constituents on the gastrointestinal tract: role of cholinergic M3 and serotonergic 5-HT3 and 5-HT4 receptors, Planta Med, 77, 973, 10.1055/s-0030-1270747 · DOI
- Pradier, 2006, A trial of a mixture of three essential oils in the treatment of postoperative nausea and vomiting, Int J Aromather, 16, 15, 10.1016/j.ijat.2006.01.004 · doi:10.1016/j.ijat.2006.01.004
- Qian, 2009, Gingerol inhibits cisplatin-induced vomiting by down regulating 5-hydroxytryptamine, dopamine and substance P expression in minks, Arch. Pharm. Res., 32, 565, 10.1007/s12272-009-1413-9 · DOI
- Qian, 2010, Effect of gingerol on substance P and NK1 receptor expression in a vomiting model of mink, Chin Med J, 123, 478
- Ramappa, 2013, Hepatotoxicity related to anti-tuberculosis drugs: mechanisms and management, J Clin Exp Hepatol, 3, 37, 10.1016/j.jceh.2012.12.001 · DOI · Paper page
- Saad, 2010, Role of oxidative stress and nitric oxide in the protective effects of alpha-lipoic acid and aminoguanidine against isoniazid-rifampicin-induced hepatotoxicity in rats, Food Chem Toxicol, 48, 1869, 10.1016/j.fct.2010.04.026 · doi:10.1016/j.fct.2010.04.026
- Saukkonen, 2006, An official ATS statement: hepatotoxicity of antituberculosis therapy, Am J Respir Crit Care Med, 174, 935, 10.1164/rccm.200510-1666ST · DOI · Paper page
- Schmid, 1994, Comparison of seven commonly used agents for prophylaxis of seasickness, J Travel Med, 1, 203, 10.1111/j.1708-8305.1994.tb00596.x · DOI
- Sistanizad, 2011, Antituberculosis drug-induced hepatotoxicity in Iranian tuberculosis patients: role of isoniazid metabolic polymorphism, Iran J Pharm Res, 10, 633
- Steele, 1991, Toxic hepatitis with isoniazid and rifampin. A meta-analysis, Chest, 99, 465, 10.1378/chest.99.2.465 · DOI · Paper page
- Sukhanov, 2012, Effectiveness of the hepatoprotective activity of reamberine, remaxol, and ademethionine and risk assessment in their use in patients with respiratory tuberculosis and drug-induced liver injury, Ter Arkh, 84, 26
- Swamy, 2012, Hepatoprotective effect of cissus quadrangularis stem extract against rifampicin-induced hepatotoxicity in rats, Indian J Pharm Sci, 74, 183, 10.4103/0250-474X.103859 · DOI
- Taramian, 2012, Side effects of first-line anti tuberculosis drugs, J Guilan Univ Med Sci, 85, 42
- Tasduq, 2005, Biochemical manifestations of anti-tuberculosis drugs induced hepatotoxicity and the effect of silymarin, Hepatol Res, 31, 132, 10.1016/j.hepres.2005.01.005 · DOI
- Thompson, 1995, Anti-tuberculosis medication and the liver: dangers and recommendations in management, Eur Respir J, 8, 1384, 10.1183/09031936.95.08081384 · DOI
- Tostmann, 2008, Antituberculosis drug-induced hepatotoxicity: concise up-to-date review, J Gastroenterol Hepatol, 23, 192, 10.1111/j.1440-1746.2007.05207.x · DOI · Paper page
- White, 2007, Ginger: an overview, Am Fam Physician, 75, 1689
- Xia, 2007, Systematic review of anti-tuberculosis drug induced adverse reactions in China, Chin J Tuberc Respir Dis (Zhonghua Jie He He Hu Xi Za Zhi), 30, 419
Cited by
Bioactive Compounds and Bioactivities of Ginger (Zingiber officinale Roscoe)
Mao, Q.-Q., Xu, X.-Y., Cao, S.-Y., Gan, R.-Y., Corke, H., Beta, T., & Li, H.-B. (2019) · Foods · doi:10.3390/foods8060185 · Cited by 1,418
Plants of the Genus Zingiber as a Source of Bioactive Phytochemicals: From Tradition to Pharmacy
Sharifi-Rad, M., Varoni, E. M., Salehi, B., Sharifi-Rad, J., Matthews, K. R., Ayatollahi, S. A., Kobarfard, F., Ibrahim, S. A., Mnayer, D., Zakaria, Z. A., et al. (2017) · Molecules · doi:10.3390/molecules22122145 · Cited by 328
Ginger in gastrointestinal disorders: A systematic review of clinical trials
Nikkhah Bodagh, M., Maleki, I., & Hekmatdoost, A. (2019) · Food Science & Nutrition · doi:10.1002/fsn3.807 · Cited by 221
Metadata
- Authors
- Emrani, Z., Shojaei, E., & Khalili, H.
- Affiliations
- Department of Clinical Pharmacy, Faculty of Pharmacy; Tehran University of Medical Sciences; Tehran Iran
- Department of Infectious Diseases, Faculty of Medicine; Tehran University of Medical Sciences; Tehran Iran
- Venue
- Phytotherapy Research
- Publisher
- Wiley
- Published
- 2016-03-07
- Volume
- 30
- Issue
- 6
- Pages
- 1003-1009
- ISSN
- 0951-418X
- Cited by
- 16
- References
- 0
- Language
- en
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Funders
- Office of Vice-Chancellor for Research of Tehran University of Medical Sciences
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ginger for Prevention of Antituberculosis-induced Gastrointestinal Adverse Reactions Including Hepatotoxicity: A Randomized Pilot Clinical Trial: Ginger and Antituberculosis Adverse Reactions. https://app.cochat.ai/papers/10.1002/ptr.5607
- The paper
- Emrani, Z., Shojaei, E., & Khalili, H. (2016). Ginger for Prevention of Antituberculosis-induced Gastrointestinal Adverse Reactions Including Hepatotoxicity: A Randomized Pilot Clinical Trial: Ginger and Antituberculosis Adverse Reactions. Phytotherapy Research. https://doi.org/10.1002/ptr.5607
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.